British American Tobacco (BATS) Today: Share Buyback Updates, Board Disclosure and What Investors Are Watching (17 December 2025)

British American Tobacco p.l.c. (LSE: BATS) published new buyback disclosures and a board-related update on 17 December 2025. Here’s what changed, why it matters, and what to watch next.

British American Tobacco p.l.c. (BAT) closed Wednesday with its shares little changed, as investors digested a fresh set of routine—but still important—regulatory filings tied to the group’s ongoing capital returns and governance disclosures.

At the close in London, British American Tobacco (BATS) was quoted around 4,284p, up 6p (+0.14%), with a market capitalisation shown at roughly £93.10bn. ^[1]

Below is a clear rundown of everything we can identify as “current news” filed/published on 17.12.2025 related to BAT (BATS), followed by the bigger picture behind the ticker.

What’s new for BATS on 17 December 2025

1) BAT reports another day of share repurchases under its buyback programme

In an RNS announcement dated 17 December 2025, BAT said it purchased 145,000 ordinary shares (25p each) from Goldman Sachs International as part of the buyback programme announced on 18 March 2024, citing authority granted at the AGM on 16 April 2025. ^[2]

Key details disclosed:

Purchase date: 16 December 2025 ^[3]
Shares purchased: 145,000 ^[4]
Price range: 4,280.00p to 4,317.00p ^[5]
VWAP: 4,297.83p ^[6]
Stated intention: the company intends to cancel the purchased shares ^[7]
Post-cancellation shares in issue (excl. treasury): 2,180,195,797 ^[8]
Treasury shares held: 132,988,352 ^[9]

Quick maths (derived from the disclosed VWAP):
145,000 shares × £42.9783 ≈ £6.23m of buybacks for that trading day.

2) A second “transaction in own shares” notice also circulated in today’s feeds

A separate market notice dated 17 December 2025 also details BAT’s purchase of 145,000 shares on 15 December 2025 (again via Goldman Sachs International), at a VWAP of 4,268.89p. ^[10]

Key disclosed figures:

Purchase date: 15 December 2025 ^[11]
Shares purchased: 145,000 ^[12]
Price range: 4,247.00p to 4,288.00p ^[13]
VWAP: 4,268.89p ^[14]
Post-cancellation shares in issue (excl. treasury): 2,180,340,797 ^[15]
Treasury shares held: 132,988,352 ^[16]

Quick maths (derived from disclosed VWAP):
145,000 shares × £42.6889 ≈ £6.19m.

Combined (two disclosed days): about £12.4m spent and 290,000 shares purchased for cancellation, based on the two filings and their stated intentions.

3) BAT discloses a board-related appointment under UK Listing Rules

BAT also published a governance disclosure stating that Karen Guerra, a Non‑Executive Director of BAT, was appointed as an Independent Director of Société BIC S.A. (listed on Euronext Paris), effective 16 December 2025. ^[17]

This type of disclosure is typically procedural, but it matters because it speaks to board commitments and transparency requirements under UK listing obligations. ^[18]

How BATS traded today

Hargreaves Lansdown’s delayed pricing page (quoted at the close on 17 December 2025) showed:

Sell/Buy: 4,284.00p / 4,285.00p ^[19]
Day high / low: 4,295.00p / 4,259.34p ^[20]
Year high / low: 4,426.00p / 2,838.00p ^[21]
Market cap: ~£93.10bn ^[22]
P/E ratio shown: 11.74 ^[23]
Dividend yield shown: 5.50% ^[24]
1-year performance shown: 43.61% (HL notes performance figures use the previous close and past performance isn’t a guide to future returns) ^[25]

Why today’s buyback disclosures matter (even when they look “routine”)

Daily buyback notices can be easy to ignore, but they do three practical things for investors:

They confirm the buyback is actively running
BAT explicitly ties the purchases to its buyback programme announced on 18 March 2024, and reiterates the mechanism (Goldman Sachs International executing purchases). ^[26]
They show the price levels management is willing to pay
The disclosed buying ranges (roughly 4,247p to 4,317p) help anchor where the company has been buying back shares recently. ^[27]
They affect the share count and (eventually) per-share metrics
Both disclosures state an intention to cancel the purchased shares and provide updated “shares in issue” totals (excluding treasury), which is the plumbing behind EPS and per-share cash return calculations. ^[28]

Governance update: Karen Guerra’s external board appointment

BAT’s disclosure about Karen Guerra joining Société BIC S.A.’s board is not the same thing as a BAT management change—but it is still a noteworthy governance item.

What it does indicate:

BAT is keeping the market informed about directors’ external commitments as required. ^[29]

What it doesn’t automatically mean:

It does not, by itself, signal any shift in BAT’s strategy, guidance, or capital allocation plans.

The broader BAT story heading into 2026

Today’s filings are happening against a much bigger investment narrative that BAT itself framed just over a week ago.

BAT’s latest outlook: on track for FY25, but cautious tone on 2026

In its 2025 Full Year Pre‑Close Trading Update (9 December 2025), BAT said it now expects about ~2% revenue and ~2% adjusted profit from operations growth for FY25, while stating that 2026 performance is expected at the lower end of its mid‑term algorithm ranges. ^[30]

That same update emphasised:

New Category revenue growth accelerating into double digits in H2, driving mid‑single‑digit growth for the full year ^[31]
Stronger momentum in the U.S., with commentary around nicotine pouches (Velo / Velo Plus) and vaping (Vuse) ^[32]
Plans for a £1.3bn share buyback for FY26, alongside a “progressive dividend” and a deleveraging path toward its leverage target range by end‑2026 ^[33]

Reuters’ reporting on that update highlighted the headwinds behind the “lower end” language—namely U.S. vape competition and regulation—while also pointing to BAT’s view that enforcement actions against illicit products were beginning to support Vuse performance. ^[34]

Capital returns: dividend timetable remains a key part of the BATS bull case

For many shareholders, BAT remains a “dividend-first” FTSE 100 name.

HL’s dividend section lists a declared 60.06p quarterly dividend with:

Ex-div date: 29 December 2025
Payment date: 4 February 2026 ^[35]

That lines up with BAT’s separate dividend finalisation disclosure earlier this week for the February 2026 instalment (not a 17 December filing, but relevant context for what income investors are watching). ^[36]

Deleveraging and asset sales: the ITC Hotels stake reduction

BAT has also been reshaping its balance sheet and simplifying “non-strategic” holdings.

Earlier in December, Reuters reported that BAT sold 9% of ITC Hotels for about $425 million, reducing its holding and framing the move as part of reducing debt and exiting a non‑strategic asset. ^[37]

BAT separately confirmed completion of a block trade of 187,500,000 shares representing 9% of ITC Hotels’ issued ordinary share capital. ^[38]

Regulatory and reputational backdrop: EU lobbying scrutiny still in focus

Tobacco remains a heavily regulated industry—and the regulatory mood can move sentiment quickly.

Reuters reported on 10 December 2025 that campaign groups said links between the tobacco industry and EU officials were underreported, adding to the ongoing scrutiny around policy influence and transparency. ^[39]

For BAT, this kind of story matters because regulatory framing can influence:

product authorisation timelines,
enforcement intensity (including against illicit vaping),
marketing restrictions and taxation trends.

Key numbers snapshot for BATS investors (as of today’s disclosures)

BATS close (London, delayed): ~4,284p (+0.14%) ^[40]
Market cap: ~£93.10bn ^[41]
Dividend yield shown: 5.50% ^[42]
Buyback disclosed today: 145,000 shares bought on 16 Dec at VWAP 4,297.83p (range 4,280p–4,317p) ^[43]
Additional buyback notice circulated today: 145,000 shares bought on 15 Dec at VWAP 4,268.89p (range 4,247p–4,288p) ^[44]
Next dividend (HL listing): 60.06p, ex‑div 29 Dec 2025, pay 4 Feb 2026 ^[45]

What to watch next for British American Tobacco (BATS)

Over the coming weeks, the market focus is likely to cluster around:

U.S. “illicit vape” enforcement momentum
BAT has explicitly tied recent Vuse improvements to early signs of stronger enforcement, while acknowledging the category pressure from illicit products. ^[46]
Evidence that New Categories can scale profitably
BAT is leaning on pouches (Velo / Velo Plus), vaping (Vuse), and heated products (glo) as the growth bridge beyond combustibles. ^[47]
How the 2026 “lower end” guidance evolves
Any shift in tone—up or down—on that mid‑term algorithm will be watched closely by both income and total‑return investors. ^[48]
Buybacks and dividend execution
Today’s disclosures show continued repurchases; the next dividend dates (ex‑div late December, payment in early February) also keep BATS firmly on the “income radar.” ^[49]

FAQ: British American Tobacco (BATS) – 17.12.2025

Did British American Tobacco buy back shares today?
BAT disclosed share repurchases in filings published on 17 December 2025, including 145,000 shares bought on 16 December at a VWAP of 4,297.83p. ^[50]

How many shares did BAT say it bought back?
The main 17 December RNS states 145,000 shares were purchased (ordinary 25p shares). ^[51]

What was the approximate value of that buyback day?
Using the disclosed VWAP, the 145,000 shares at 4,297.83p implies roughly £6.23m of purchases (calculated from the filing’s numbers). ^[52]

What’s the latest on BAT’s dividend schedule?
HL shows a declared 60.06p dividend with an ex‑div date of 29 December 2025 and a payment date of 4 February 2026. ^[53]

What was the board-related announcement today?
BAT disclosed that non‑executive director Karen Guerra was appointed an independent director of Société BIC S.A., effective 16 December 2025. ^[54]

Note: This article is informational and based on cited public disclosures and reporting; it is not investment advice.